Archimedes, a San Francisco-based health care data modeling company owned by Kaiser Permanente, has been sold to Evidera, a health care software company owned by private equity firm Symphony Technology Group.
Financial terms were not disclosed in a joint statement released Wednesday.
Dr. David Eddy, Archimedes’ co-founder, said the sale “opens up an exciting new chapter” in its 20-year campaign to use quantitative methods to improve health care quality and control costs.
Symphony Technology is based in Palo Alto, but its Evidera subsidiary is based in Bethesda, Md., with another West Coast outpost in Seattle.
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
Jed Weissberg, M.D., a Kaiser senior vice president in charge of quality issues, called Symphony/Evidera “a great home” for Archimedes’ researchers, who combine real world data and computer simulations to help support clinical decision making.
Back in 2009, Archimedes said it was charging hospitals, pharmaceutical companies and other health care entities from $100,000 to “multiple millions” to analyze situations for them.
Since then, though the San Francisco technology firm has been notably reluctant to share any financial information.
At that time, it had 61 employees, and counted among its customers Kaiser Permanente, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, and Japan’s Daiichi Sankyo Co.; GE Healthcare; the federal Centers for Disease Control; the American Cancer Society; American Diabetes Association, and American Heart Association.
Date: Jan 9, 2014